首页 › 癌症（所有类型） › 弗吉尼亚州 › Arlington
Arlington VA 癌症（所有类型）临床试验
48项针对 癌症（所有类型）的研究正在 Arlington及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
招募中2 期
- Next Virginia /ID# 279684, Fairfax · 距离 11 英里
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
招募中2 期
- Virginia Cancer Specialists ( Site 1102), Fairfax · 距离 11 英里
A Study of ASP3082 in Adults With Advanced Solid Tumors
招募中1 期
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 距离 11 英里
REC-7735 in Participants With Solid Tumors
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
Registry Study for Radiation Therapy Outcomes
招募中观察性研究
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Fairfax · 距离 11 英里
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
招募中3 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
招募中1 期
- NEXT Oncology, Fairfax · 距离 11 英里
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
招募中3 期
- Inova Schar Cancer Institute Clinical Trials, Fairfax · 距离 11 英里
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中3 期
- Virginia Cancer Specialists - Fairfax /ID# 280710, Fairfax · 距离 11 英里
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
招募中1 期
- NEXT Virginia ( Site 0054), Fairfax · 距离 11 英里
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
招募中1 期
- Investigational Site number: 404, Fairfax · 距离 11 英里
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, Fairfax · 距离 11 英里
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- USO - Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
招募中1 期
- NEXT Oncology, Fairfax · 距离 11 英里
Project: Every Child for Younger Patients With Cancer
招募中观察性研究
- Inova Fairfax Hospital, Falls Church · 距离 4 英里
A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A Study of ASP1002 in Adults for Treatment of Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
招募中2 期
- 522, Fairfax · 距离 11 英里
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
招募中1 期
- Virginia Cancer Specialists - Fairfax /ID# 268559, Fairfax · 距离 11 英里
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
招募中2 期
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · 距离 11 英里
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · 距离 11 英里
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- USO-Virginia Cancer Specialists, PC, Fairfax · 距离 11 英里
Burn Pit Exposure in Veterans: A Cancer Screening Pilot Study at the Inova Saville Cancer Screening & Prevention Center
招募中欢迎健康志愿者
- Inova Schar Cancer Institute, Fairfax · 距离 11 英里
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
招募中1/2 期
- NEXT, Fairfax · 距离 11 英里
Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System
招募中
- Inova Schar Cancer - Saville Cancer Screening and Prevention Center, Fairfax · 距离 11 英里
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, Fairfax · 距离 11 英里
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
招募中2/3 期
- Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax · 距离 11 英里
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
招募中1 期
- NEXT Oncology - Virginia, Fairfax · 距离 11 英里
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
招募中1/2 期
- NEXT Oncology, Fairfax · 距离 11 英里
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
招募中1 期
- NEXT Virginia, Fairfax · 距离 11 英里
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
招募中1 期
- NEXT Virigina, Fairfax · 距离 11 英里
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
招募中1 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
招募中1/2 期
- Virginia Cancer Specialists, Fairfax · 距离 11 英里
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
招募中1/2 期
- NEXT Virginia, Fairfax · 距离 11 英里
A Study in Patients With Advanced Cancers
招募中1/2 期
- NEXT Oncology Virginia, Fairfax · 距离 11 英里
其他城市的 癌症（所有类型）试验
- Houston, TX121 项研究
- New York City, NY110 项研究
- Boston, MA86 项研究
- Los Angeles, CA73 项研究
- Nashville, TN65 项研究
- Philadelphia, PA59 项研究
- Durham, NC58 项研究
- Washington, DC58 项研究
- Chicago, IL51 项研究
- Seattle, WA49 项研究
- Atlanta, GA49 项研究
- St. Louis, MO46 项研究
Arlington的其他研究
- 非小细胞肺癌104 项研究
- 转移性癌症53 项研究
- 结直肠癌52 项研究
- 乳腺癌46 项研究
- 卵巢癌46 项研究
- 肺癌41 项研究
- 子宫内膜癌39 项研究
- 胰腺癌33 项研究
- 头颈鳞状细胞癌26 项研究
- 小细胞肺癌23 项研究
- 三阴性乳腺癌20 项研究
- 胃癌20 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。